SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-111106
Filing Date
2021-08-30
Accepted
2021-08-30 17:07:47
Documents
12
Period of Report
2021-08-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2126424d1_8k.htm   iXBRL 8-K 85578
  Complete submission text file 0001104659-21-111106.txt   272377

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sbbp-20210830.xsd EX-101.SCH 3209
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbbp-20210830_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbbp-20210830_pre.xml EX-101.PRE 22726
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2126424d1_8k_htm.xml XML 3613
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 211224373
SIC: 2834 Pharmaceutical Preparations